Transgenomic, Inc. (NASDAQ: TBIO), a global biotechnology company advancing personalized medicine in cardiology, oncology, and inherited diseases through advanced diagnostic tests and clinical and research services, today announced that educational materials discussing its ICE COLD-PCR (ICP) technology will be available at its booth at the 2014 ASCO Annual Meeting.
Help employers find you! Check out all the jobs and post your resume.
